Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Contraceptives Market Growth 2022-2028

  • LP 4713221
  • 110 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Contraceptives will have significant change from previous year. According to our (LP Information) latest study, the global Contraceptives market size is USD million in 2022 from USD 1870.3 million in 2021, with a change of % between 2021 and 2022. The global Contraceptives market size will reach USD 2237.4 million in 2028, growing at a CAGR of 2.6% over the analysis period.

The United States Contraceptives market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Contraceptives market, reaching US$ million by the year 2028. As for the Europe Contraceptives landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Contraceptives players cover Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, and Merck & Co., Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Contraceptives market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Pills

Injectable

Condoms

Vaginal Rings

IUDs

Subdermal Implants

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

15–24 years

25–34 years

35–44 years

Above 44 years

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Bayer AG

Pfizer, Inc

Teva Pharmaceutical Industries Ltd

Merck & Co., Inc

Actavis, Inc.

Johnson & Johnson

Gedeon Richter

Novo Nordisk A/S

ZiZhu

Baijingyu

Huazhong

Sine

Reckitt

AbbVie

Church & Dwight

The Cooper Companies

TherapeuticsMD

Afaxys

Mithra Pharmaceuticals

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Contraceptives Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Contraceptives by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Contraceptives by Country/Region, 2017, 2022 & 2028

2.2 Contraceptives Segment by Type

2.2.1 Pills

2.2.2 Injectable

2.2.3 Condoms

2.2.4 Vaginal Rings

2.2.5 IUDs

2.2.6 Subdermal Implants

2.2.7 Others

2.3 Contraceptives Sales by Type

2.3.1 Global Contraceptives Sales Market Share by Type (2017-2022)

2.3.2 Global Contraceptives Revenue and Market Share by Type (2017-2022)

2.3.3 Global Contraceptives Sale Price by Type (2017-2022)

2.4 Contraceptives Segment by End User

2.4.1 15–24 years

2.4.2 25–34 years

2.4.3 35–44 years

2.4.4 Above 44 years

2.5 Contraceptives Sales by End User

2.5.1 Global Contraceptives Sale Market Share by End User (2017-2022)

2.5.2 Global Contraceptives Revenue and Market Share by End User (2017-2022)

2.5.3 Global Contraceptives Sale Price by End User (2017-2022)

3 Global Contraceptives by Company

3.1 Global Contraceptives Breakdown Data by Company

3.1.1 Global Contraceptives Annual Sales by Company (2020-2022)

3.1.2 Global Contraceptives Sales Market Share by Company (2020-2022)

3.2 Global Contraceptives Annual Revenue by Company (2020-2022)

3.2.1 Global Contraceptives Revenue by Company (2020-2022)

3.2.2 Global Contraceptives Revenue Market Share by Company (2020-2022)

3.3 Global Contraceptives Sale Price by Company

3.4 Key Manufacturers Contraceptives Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Contraceptives Product Location Distribution

3.4.2 Players Contraceptives Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Contraceptives by Geographic Region

4.1 World Historic Contraceptives Market Size by Geographic Region (2017-2022)

4.1.1 Global Contraceptives Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Contraceptives Annual Revenue by Geographic Region

4.2 World Historic Contraceptives Market Size by Country/Region (2017-2022)

4.2.1 Global Contraceptives Annual Sales by Country/Region (2017-2022)

4.2.2 Global Contraceptives Annual Revenue by Country/Region

4.3 Americas Contraceptives Sales Growth

4.4 APAC Contraceptives Sales Growth

4.5 Europe Contraceptives Sales Growth

4.6 Middle East & Africa Contraceptives Sales Growth

5 Americas

5.1 Americas Contraceptives Sales by Country

5.1.1 Americas Contraceptives Sales by Country (2017-2022)

5.1.2 Americas Contraceptives Revenue by Country (2017-2022)

5.2 Americas Contraceptives Sales by Type

5.3 Americas Contraceptives Sales by End User

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Contraceptives Sales by Region

6.1.1 APAC Contraceptives Sales by Region (2017-2022)

6.1.2 APAC Contraceptives Revenue by Region (2017-2022)

6.2 APAC Contraceptives Sales by Type

6.3 APAC Contraceptives Sales by End User

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Contraceptives by Country

7.1.1 Europe Contraceptives Sales by Country (2017-2022)

7.1.2 Europe Contraceptives Revenue by Country (2017-2022)

7.2 Europe Contraceptives Sales by Type

7.3 Europe Contraceptives Sales by End User

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Contraceptives by Country

8.1.1 Middle East & Africa Contraceptives Sales by Country (2017-2022)

8.1.2 Middle East & Africa Contraceptives Revenue by Country (2017-2022)

8.2 Middle East & Africa Contraceptives Sales by Type

8.3 Middle East & Africa Contraceptives Sales by End User

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Contraceptives

10.3 Manufacturing Process Analysis of Contraceptives

10.4 Industry Chain Structure of Contraceptives

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Contraceptives Distributors

11.3 Contraceptives Customer

12 World Forecast Review for Contraceptives by Geographic Region

12.1 Global Contraceptives Market Size Forecast by Region

12.1.1 Global Contraceptives Forecast by Region (2023-2028)

12.1.2 Global Contraceptives Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Contraceptives Forecast by Type

12.7 Global Contraceptives Forecast by End User

13 Key Players Analysis

13.1 Bayer AG

13.1.1 Bayer AG Company Information

13.1.2 Bayer AG Contraceptives Product Offered

13.1.3 Bayer AG Contraceptives Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bayer AG Main Business Overview

13.1.5 Bayer AG Latest Developments

13.2 Pfizer, Inc

13.2.1 Pfizer, Inc Company Information

13.2.2 Pfizer, Inc Contraceptives Product Offered

13.2.3 Pfizer, Inc Contraceptives Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Pfizer, Inc Main Business Overview

13.2.5 Pfizer, Inc Latest Developments

13.3 Teva Pharmaceutical Industries Ltd

13.3.1 Teva Pharmaceutical Industries Ltd Company Information

13.3.2 Teva Pharmaceutical Industries Ltd Contraceptives Product Offered

13.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Teva Pharmaceutical Industries Ltd Main Business Overview

13.3.5 Teva Pharmaceutical Industries Ltd Latest Developments

13.4 Merck & Co., Inc

13.4.1 Merck & Co., Inc Company Information

13.4.2 Merck & Co., Inc Contraceptives Product Offered

13.4.3 Merck & Co., Inc Contraceptives Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Merck & Co., Inc Main Business Overview

13.4.5 Merck & Co., Inc Latest Developments

13.5 Actavis, Inc.

13.5.1 Actavis, Inc. Company Information

13.5.2 Actavis, Inc. Contraceptives Product Offered

13.5.3 Actavis, Inc. Contraceptives Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Actavis, Inc. Main Business Overview

13.5.5 Actavis, Inc. Latest Developments

13.6 Johnson & Johnson

13.6.1 Johnson & Johnson Company Information

13.6.2 Johnson & Johnson Contraceptives Product Offered

13.6.3 Johnson & Johnson Contraceptives Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Johnson & Johnson Main Business Overview

13.6.5 Johnson & Johnson Latest Developments

13.7 Gedeon Richter

13.7.1 Gedeon Richter Company Information

13.7.2 Gedeon Richter Contraceptives Product Offered

13.7.3 Gedeon Richter Contraceptives Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Gedeon Richter Main Business Overview

13.7.5 Gedeon Richter Latest Developments

13.8 Novo Nordisk A/S

13.8.1 Novo Nordisk A/S Company Information

13.8.2 Novo Nordisk A/S Contraceptives Product Offered

13.8.3 Novo Nordisk A/S Contraceptives Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Novo Nordisk A/S Main Business Overview

13.8.5 Novo Nordisk A/S Latest Developments

13.9 ZiZhu

13.9.1 ZiZhu Company Information

13.9.2 ZiZhu Contraceptives Product Offered

13.9.3 ZiZhu Contraceptives Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 ZiZhu Main Business Overview

13.9.5 ZiZhu Latest Developments

13.10 Baijingyu

13.10.1 Baijingyu Company Information

13.10.2 Baijingyu Contraceptives Product Offered

13.10.3 Baijingyu Contraceptives Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Baijingyu Main Business Overview

13.10.5 Baijingyu Latest Developments

13.11 Huazhong

13.11.1 Huazhong Company Information

13.11.2 Huazhong Contraceptives Product Offered

13.11.3 Huazhong Contraceptives Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Huazhong Main Business Overview

13.11.5 Huazhong Latest Developments

13.12 Sine

13.12.1 Sine Company Information

13.12.2 Sine Contraceptives Product Offered

13.12.3 Sine Contraceptives Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Sine Main Business Overview

13.12.5 Sine Latest Developments

13.13 Reckitt

13.13.1 Reckitt Company Information

13.13.2 Reckitt Contraceptives Product Offered

13.13.3 Reckitt Contraceptives Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Reckitt Main Business Overview

13.13.5 Reckitt Latest Developments

13.14 AbbVie

13.14.1 AbbVie Company Information

13.14.2 AbbVie Contraceptives Product Offered

13.14.3 AbbVie Contraceptives Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 AbbVie Main Business Overview

13.14.5 AbbVie Latest Developments

13.15 Church & Dwight

13.15.1 Church & Dwight Company Information

13.15.2 Church & Dwight Contraceptives Product Offered

13.15.3 Church & Dwight Contraceptives Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Church & Dwight Main Business Overview

13.15.5 Church & Dwight Latest Developments

13.16 The Cooper Companies

13.16.1 The Cooper Companies Company Information

13.16.2 The Cooper Companies Contraceptives Product Offered

13.16.3 The Cooper Companies Contraceptives Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 The Cooper Companies Main Business Overview

13.16.5 The Cooper Companies Latest Developments

13.17 TherapeuticsMD

13.17.1 TherapeuticsMD Company Information

13.17.2 TherapeuticsMD Contraceptives Product Offered

13.17.3 TherapeuticsMD Contraceptives Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 TherapeuticsMD Main Business Overview

13.17.5 TherapeuticsMD Latest Developments

13.18 Afaxys

13.18.1 Afaxys Company Information

13.18.2 Afaxys Contraceptives Product Offered

13.18.3 Afaxys Contraceptives Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Afaxys Main Business Overview

13.18.5 Afaxys Latest Developments

13.19 Mithra Pharmaceuticals

13.19.1 Mithra Pharmaceuticals Company Information

13.19.2 Mithra Pharmaceuticals Contraceptives Product Offered

13.19.3 Mithra Pharmaceuticals Contraceptives Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Mithra Pharmaceuticals Main Business Overview

13.19.5 Mithra Pharmaceuticals Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Contraceptives Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Contraceptives Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Pills

Table 4. Major Players of Injectable

Table 5. Major Players of Condoms

Table 6. Major Players of Vaginal Rings

Table 7. Major Players of IUDs

Table 8. Major Players of Subdermal Implants

Table 9. Major Players of Others

Table 10. Global Contraceptives Sales by Type (2017-2022) & (M Units)

Table 11. Global Contraceptives Sales Market Share by Type (2017-2022)

Table 12. Global Contraceptives Revenue by Type (2017-2022) & ($ million)

Table 13. Global Contraceptives Revenue Market Share by Type (2017-2022)

Table 14. Global Contraceptives Sale Price by Type (2017-2022) & (USD/Unit)

Table 15. Global Contraceptives Sales by End User (2017-2022) & (M Units)

Table 16. Global Contraceptives Sales Market Share by End User (2017-2022)

Table 17. Global Contraceptives Revenue by End User (2017-2022)

Table 18. Global Contraceptives Revenue Market Share by End User (2017-2022)

Table 19. Global Contraceptives Sale Price by End User (2017-2022) & (USD/Unit)

Table 20. Global Contraceptives Sales by Company (2020-2022) & (M Units)

Table 21. Global Contraceptives Sales Market Share by Company (2020-2022)

Table 22. Global Contraceptives Revenue by Company (2020-2022) ($ Millions)

Table 23. Global Contraceptives Revenue Market Share by Company (2020-2022)

Table 24. Global Contraceptives Sale Price by Company (2020-2022) & (USD/Unit)

Table 25. Key Manufacturers Contraceptives Producing Area Distribution and Sales Area

Table 26. Players Contraceptives Products Offered

Table 27. Contraceptives Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 28. New Products and Potential Entrants

Table 29. Mergers & Acquisitions, Expansion

Table 30. Global Contraceptives Sales by Geographic Region (2017-2022) & (M Units)

Table 31. Global Contraceptives Sales Market Share Geographic Region (2017-2022)

Table 32. Global Contraceptives Revenue by Geographic Region (2017-2022) & ($ millions)

Table 33. Global Contraceptives Revenue Market Share by Geographic Region (2017-2022)

Table 34. Global Contraceptives Sales by Country/Region (2017-2022) & (M Units)

Table 35. Global Contraceptives Sales Market Share by Country/Region (2017-2022)

Table 36. Global Contraceptives Revenue by Country/Region (2017-2022) & ($ millions)

Table 37. Global Contraceptives Revenue Market Share by Country/Region (2017-2022)

Table 38. Americas Contraceptives Sales by Country (2017-2022) & (M Units)

Table 39. Americas Contraceptives Sales Market Share by Country (2017-2022)

Table 40. Americas Contraceptives Revenue by Country (2017-2022) & ($ Millions)

Table 41. Americas Contraceptives Revenue Market Share by Country (2017-2022)

Table 42. Americas Contraceptives Sales by Type (2017-2022) & (M Units)

Table 43. Americas Contraceptives Sales Market Share by Type (2017-2022)

Table 44. Americas Contraceptives Sales by End User (2017-2022) & (M Units)

Table 45. Americas Contraceptives Sales Market Share by End User (2017-2022)

Table 46. APAC Contraceptives Sales by Region (2017-2022) & (M Units)

Table 47. APAC Contraceptives Sales Market Share by Region (2017-2022)

Table 48. APAC Contraceptives Revenue by Region (2017-2022) & ($ Millions)

Table 49. APAC Contraceptives Revenue Market Share by Region (2017-2022)

Table 50. APAC Contraceptives Sales by Type (2017-2022) & (M Units)

Table 51. APAC Contraceptives Sales Market Share by Type (2017-2022)

Table 52. APAC Contraceptives Sales by End User (2017-2022) & (M Units)

Table 53. APAC Contraceptives Sales Market Share by End User (2017-2022)

Table 54. Europe Contraceptives Sales by Country (2017-2022) & (M Units)

Table 55. Europe Contraceptives Sales Market Share by Country (2017-2022)

Table 56. Europe Contraceptives Revenue by Country (2017-2022) & ($ Millions)

Table 57. Europe Contraceptives Revenue Market Share by Country (2017-2022)

Table 58. Europe Contraceptives Sales by Type (2017-2022) & (M Units)

Table 59. Europe Contraceptives Sales Market Share by Type (2017-2022)

Table 60. Europe Contraceptives Sales by End User (2017-2022) & (M Units)

Table 61. Europe Contraceptives Sales Market Share by End User (2017-2022)

Table 62. Middle East & Africa Contraceptives Sales by Country (2017-2022) & (M Units)

Table 63. Middle East & Africa Contraceptives Sales Market Share by Country (2017-2022)

Table 64. Middle East & Africa Contraceptives Revenue by Country (2017-2022) & ($ Millions)

Table 65. Middle East & Africa Contraceptives Revenue Market Share by Country (2017-2022)

Table 66. Middle East & Africa Contraceptives Sales by Type (2017-2022) & (M Units)

Table 67. Middle East & Africa Contraceptives Sales Market Share by Type (2017-2022)

Table 68. Middle East & Africa Contraceptives Sales by End User (2017-2022) & (M Units)

Table 69. Middle East & Africa Contraceptives Sales Market Share by End User (2017-2022)

Table 70. Key Market Drivers & Growth Opportunities of Contraceptives

Table 71. Key Market Challenges & Risks of Contraceptives

Table 72. Key Industry Trends of Contraceptives

Table 73. Contraceptives Raw Material

Table 74. Key Suppliers of Raw Materials

Table 75. Contraceptives Distributors List

Table 76. Contraceptives Customer List

Table 77. Global Contraceptives Sales Forecast by Region (2023-2028) & (M Units)

Table 78. Global Contraceptives Sales Market Forecast by Region

Table 79. Global Contraceptives Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Global Contraceptives Revenue Market Share Forecast by Region (2023-2028)

Table 81. Americas Contraceptives Sales Forecast by Country (2023-2028) & (M Units)

Table 82. Americas Contraceptives Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. APAC Contraceptives Sales Forecast by Region (2023-2028) & (M Units)

Table 84. APAC Contraceptives Revenue Forecast by Region (2023-2028) & ($ millions)

Table 85. Europe Contraceptives Sales Forecast by Country (2023-2028) & (M Units)

Table 86. Europe Contraceptives Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Middle East & Africa Contraceptives Sales Forecast by Country (2023-2028) & (M Units)

Table 88. Middle East & Africa Contraceptives Revenue Forecast by Country (2023-2028) & ($ millions)

Table 89. Global Contraceptives Sales Forecast by Type (2023-2028) & (M Units)

Table 90. Global Contraceptives Sales Market Share Forecast by Type (2023-2028)

Table 91. Global Contraceptives Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 92. Global Contraceptives Revenue Market Share Forecast by Type (2023-2028)

Table 93. Global Contraceptives Sales Forecast by End User (2023-2028) & (M Units)

Table 94. Global Contraceptives Sales Market Share Forecast by End User (2023-2028)

Table 95. Global Contraceptives Revenue Forecast by End User (2023-2028) & ($ Millions)

Table 96. Global Contraceptives Revenue Market Share Forecast by End User (2023-2028)

Table 97. Bayer AG Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors

Table 98. Bayer AG Contraceptives Product Offered

Table 99. Bayer AG Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Bayer AG Main Business

Table 101. Bayer AG Latest Developments

Table 102. Pfizer, Inc Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors

Table 103. Pfizer, Inc Contraceptives Product Offered

Table 104. Pfizer, Inc Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Pfizer, Inc Main Business

Table 106. Pfizer, Inc Latest Developments

Table 107. Teva Pharmaceutical Industries Ltd Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors

Table 108. Teva Pharmaceutical Industries Ltd Contraceptives Product Offered

Table 109. Teva Pharmaceutical Industries Ltd Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Teva Pharmaceutical Industries Ltd Main Business

Table 111. Teva Pharmaceutical Industries Ltd Latest Developments

Table 112. Merck & Co., Inc Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors

Table 113. Merck & Co., Inc Contraceptives Product Offered

Table 114. Merck & Co., Inc Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Merck & Co., Inc Main Business

Table 116. Merck & Co., Inc Latest Developments

Table 117. Actavis, Inc. Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors

Table 118. Actavis, Inc. Contraceptives Product Offered

Table 119. Actavis, Inc. Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Actavis, Inc. Main Business

Table 121. Actavis, Inc. Latest Developments

Table 122. Johnson & Johnson Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors

Table 123. Johnson & Johnson Contraceptives Product Offered

Table 124. Johnson & Johnson Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Johnson & Johnson Main Business

Table 126. Johnson & Johnson Latest Developments

Table 127. Gedeon Richter Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors

Table 128. Gedeon Richter Contraceptives Product Offered

Table 129. Gedeon Richter Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Gedeon Richter Main Business

Table 131. Gedeon Richter Latest Developments

Table 132. Novo Nordisk A/S Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors

Table 133. Novo Nordisk A/S Contraceptives Product Offered

Table 134. Novo Nordisk A/S Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. Novo Nordisk A/S Main Business

Table 136. Novo Nordisk A/S Latest Developments

Table 137. ZiZhu Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors

Table 138. ZiZhu Contraceptives Product Offered

Table 139. ZiZhu Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. ZiZhu Main Business

Table 141. ZiZhu Latest Developments

Table 142. Baijingyu Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors

Table 143. Baijingyu Contraceptives Product Offered

Table 144. Baijingyu Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 145. Baijingyu Main Business

Table 146. Baijingyu Latest Developments

Table 147. Huazhong Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors

Table 148. Huazhong Contraceptives Product Offered

Table 149. Huazhong Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 150. Huazhong Main Business

Table 151. Huazhong Latest Developments

Table 152. Sine Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors

Table 153. Sine Contraceptives Product Offered

Table 154. Sine Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 155. Sine Main Business

Table 156. Sine Latest Developments

Table 157. Reckitt Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors

Table 158. Reckitt Contraceptives Product Offered

Table 159. Reckitt Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 160. Reckitt Main Business

Table 161. Reckitt Latest Developments

Table 162. AbbVie Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors

Table 163. AbbVie Contraceptives Product Offered

Table 164. AbbVie Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 165. AbbVie Main Business

Table 166. AbbVie Latest Developments

Table 167. Church & Dwight Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors

Table 168. Church & Dwight Contraceptives Product Offered

Table 169. Church & Dwight Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 170. Church & Dwight Main Business

Table 171. Church & Dwight Latest Developments

Table 172. The Cooper Companies Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors

Table 173. The Cooper Companies Contraceptives Product Offered

Table 174. The Cooper Companies Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 175. The Cooper Companies Main Business

Table 176. The Cooper Companies Latest Developments

Table 177. TherapeuticsMD Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors

Table 178. TherapeuticsMD Contraceptives Product Offered

Table 179. TherapeuticsMD Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 180. TherapeuticsMD Main Business

Table 181. TherapeuticsMD Latest Developments

Table 182. Afaxys Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors

Table 183. Afaxys Contraceptives Product Offered

Table 184. Afaxys Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 185. Afaxys Main Business

Table 186. Afaxys Latest Developments

Table 187. Mithra Pharmaceuticals Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors

Table 188. Mithra Pharmaceuticals Contraceptives Product Offered

Table 189. Mithra Pharmaceuticals Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 190. Mithra Pharmaceuticals Main Business

Table 191. Mithra Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Contraceptives

Figure 2. Contraceptives Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Contraceptives Sales Growth Rate 2017-2028 (M Units)

Figure 7. Global Contraceptives Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Contraceptives Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Pills

Figure 10. Product Picture of Injectable

Figure 11. Product Picture of Condoms

Figure 12. Product Picture of Vaginal Rings

Figure 13. Product Picture of IUDs

Figure 14. Product Picture of Subdermal Implants

Figure 15. Product Picture of Others

Figure 16. Global Contraceptives Sales Market Share by Type in 2021

Figure 17. Global Contraceptives Revenue Market Share by Type (2017-2022)

Figure 18. Contraceptives Consumed in 15–24 years

Figure 19. Global Contraceptives Market: 15–24 years (2017-2022) & (M Units)

Figure 20. Contraceptives Consumed in 25–34 years

Figure 21. Global Contraceptives Market: 25–34 years (2017-2022) & (M Units)

Figure 22. Contraceptives Consumed in 35–44 years

Figure 23. Global Contraceptives Market: 35–44 years (2017-2022) & (M Units)

Figure 24. Contraceptives Consumed in Above 44 years

Figure 25. Global Contraceptives Market: Above 44 years (2017-2022) & (M Units)

Figure 26. Global Contraceptives Sales Market Share by End User (2017-2022)

Figure 27. Global Contraceptives Revenue Market Share by End User in 2021

Figure 28. Contraceptives Revenue Market by Company in 2021 ($ Million)

Figure 29. Global Contraceptives Revenue Market Share by Company in 2021

Figure 30. Global Contraceptives Sales Market Share by Geographic Region (2017-2022)

Figure 31. Global Contraceptives Revenue Market Share by Geographic Region in 2021

Figure 32. Global Contraceptives Sales Market Share by Region (2017-2022)

Figure 33. Global Contraceptives Revenue Market Share by Country/Region in 2021

Figure 34. Americas Contraceptives Sales 2017-2022 (M Units)

Figure 35. Americas Contraceptives Revenue 2017-2022 ($ Millions)

Figure 36. APAC Contraceptives Sales 2017-2022 (M Units)

Figure 37. APAC Contraceptives Revenue 2017-2022 ($ Millions)

Figure 38. Europe Contraceptives Sales 2017-2022 (M Units)

Figure 39. Europe Contraceptives Revenue 2017-2022 ($ Millions)

Figure 40. Middle East & Africa Contraceptives Sales 2017-2022 (M Units)

Figure 41. Middle East & Africa Contraceptives Revenue 2017-2022 ($ Millions)

Figure 42. Americas Contraceptives Sales Market Share by Country in 2021

Figure 43. Americas Contraceptives Revenue Market Share by Country in 2021

Figure 44. United States Contraceptives Revenue Growth 2017-2022 ($ Millions)

Figure 45. Canada Contraceptives Revenue Growth 2017-2022 ($ Millions)

Figure 46. Mexico Contraceptives Revenue Growth 2017-2022 ($ Millions)

Figure 47. Brazil Contraceptives Revenue Growth 2017-2022 ($ Millions)

Figure 48. APAC Contraceptives Sales Market Share by Region in 2021

Figure 49. APAC Contraceptives Revenue Market Share by Regions in 2021

Figure 50. China Contraceptives Revenue Growth 2017-2022 ($ Millions)

Figure 51. Japan Contraceptives Revenue Growth 2017-2022 ($ Millions)

Figure 52. South Korea Contraceptives Revenue Growth 2017-2022 ($ Millions)

Figure 53. Southeast Asia Contraceptives Revenue Growth 2017-2022 ($ Millions)

Figure 54. India Contraceptives Revenue Growth 2017-2022 ($ Millions)

Figure 55. Australia Contraceptives Revenue Growth 2017-2022 ($ Millions)

Figure 56. Europe Contraceptives Sales Market Share by Country in 2021

Figure 57. Europe Contraceptives Revenue Market Share by Country in 2021

Figure 58. Germany Contraceptives Revenue Growth 2017-2022 ($ Millions)

Figure 59. France Contraceptives Revenue Growth 2017-2022 ($ Millions)

Figure 60. UK Contraceptives Revenue Growth 2017-2022 ($ Millions)

Figure 61. Italy Contraceptives Revenue Growth 2017-2022 ($ Millions)

Figure 62. Russia Contraceptives Revenue Growth 2017-2022 ($ Millions)

Figure 63. Middle East & Africa Contraceptives Sales Market Share by Country in 2021

Figure 64. Middle East & Africa Contraceptives Revenue Market Share by Country in 2021

Figure 65. Egypt Contraceptives Revenue Growth 2017-2022 ($ Millions)

Figure 66. South Africa Contraceptives Revenue Growth 2017-2022 ($ Millions)

Figure 67. Israel Contraceptives Revenue Growth 2017-2022 ($ Millions)

Figure 68. Turkey Contraceptives Revenue Growth 2017-2022 ($ Millions)

Figure 69. GCC Country Contraceptives Revenue Growth 2017-2022 ($ Millions)

Figure 70. Manufacturing Cost Structure Analysis of Contraceptives in 2021

Figure 71. Manufacturing Process Analysis of Contraceptives

Figure 72. Industry Chain Structure of Contraceptives

Figure 73. Channels of Distribution

Figure 74. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390